Rocamed Inc.

Rocamed Inc. is a Monaco-based medical device manufacturer specializing in innovative, sterile, and disposable products for urology, gynecology, and laparoscopy. Founded in 2009 as part of the PROMEPLA group and now majority-owned by 21 Invest, the company designs and distributes endo-urological devices compliant with European, international, and FDA standards. With 4 manufacturing sites and distribution across 65+ countries, Rocamed serves urologists and gynecologists globally. The company maintains strong clinical engagement through physician collaboration, training programs, and presence at major international congresses including EAU, AUA, and BAUS. Rocamed's product portfolio focuses on minimally invasive urological solutions including laser systems, ureteral stents, stone retrieval instruments, and prostatic devices.